3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
13
Specimen Handling
9
cabozantinib
8
X-Rays
8
Magnetic Resonance Spectroscopy
8
fludarabine
7
Phantoms, Imaging
7
Biopsy
7
Temozolomide
6
Methotrexate
6
Zoledronic Acid
5
Gemcitabine
5
Doxorubicin
5
regorafenib
4
pembrolizumab
4
Vincristine
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Ifosfamide
4
Cisplatin
4
olaparib
3
irinotecan sucrosofate
3
fludarabine phosphate
3
dinutuximab
3
Surveys and Questionnaires
3
Irinotecan
3
Etoposide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
IL32 protein, human
×
1 year
×
Clear all
No trials found.